Colgate Palmolive Co SEC Filings

Colgate-Palmolive's Chairman, President & CEO received equity awards on 09/11/2025 consisting of 28,314 restricted stock units and a stock option for 196,047 shares with an exercise price of $84.06. The restricted stock units vest in three equal annual installments starting one year after grant, and the option vests in equal annual installments over three years beginning one year after the grant, with an expiration in 2033. Following the transaction the reporting person directly beneficially owns 347,464 shares, and holds additional indirect holdings of 53,560 shares via the issuer's 401(k) trustee, 52,000 shares via a spouse trust, and 335 shares via another trust. The awards were reported on a Form 4 reflecting standard compensation plan grants to an executive director.

Tsourapas Panagiotis, Colgate-Palmolive Company COO (Eur., APac, Afr Eur, Skin) reported equity awards on 09/11/2025. The filing shows a grant of 4,759 restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant. The report also discloses 32,949 stock options with an exercise price of $84.06; the options vest in equal annual installments over three years beginning on 09/11/2026 and expire on 09/11/2033. Following the transactions, the reporting person directly beneficially owns 11,996 shares and beneficially owns additional shares indirectly: 4,509 via the issuer's 401(k) plan trustee and 60,745 via trust (which includes 10,774 previously reported as direct). The form was signed 09/12/2025.

Colgate-Palmolive's chief financial officer received equity awards from the company as disclosed on a Section 16 filing. The filing shows a grant of 8,328 restricted stock units and a stock option for 57,661 underlying shares with an exercise price of $84.06 and an expiration in 2033. After the reported transactions the reporting person beneficially owned 57,732 shares directly and held 324 shares indirectly through the issuer's 401(k) plan trustee. The restricted stock units vest in three equal annual installments and the option vests in equal annual installments over three years.

Parameswaran Prabha, Vice Chair and officer of Colgate-Palmolive Company (CL), reported equity awards granted on 09/11/2025. The filing shows a grant of 4,592 restricted stock units (RSUs) that vest in three equal annual installments starting one year after grant and a stock option award covering 31,796 shares with an exercise price of $84.06, exercisable in equal annual installments over three years and expiring 09/11/2033. After the RSU grant, Mr. Prabha directly beneficially owns 12,696 shares. The filing also reports 5,955 shares held indirectly by the issuer's 401(k) plan trustee and 46,810 shares held indirectly by a trust (which includes 9,980 shares previously reported).

Insider awards and holdings reported for Colgate-Palmolive (CL). On 09/11/2025 the reporting person received a restricted stock unit (RSU) award of 3,450 shares that vests in three equal annual installments, and a stock option to buy 23,888 shares with an exercise price of $84.06. The option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the grant and expires on 09/11/2033.

Following the reported transactions the reporting person beneficially owned 16,062 shares directly and 8,004 shares indirectly through the issuer's 401(k) plan trustee. The report was signed by an attorney-in-fact on 09/12/2025.

Colgate-Palmolive officer Hazlin John reported equity awards granted on 09/11/2025. The filing shows a grant of 4,045 restricted stock units (RSUs) and a stock option award covering 28,007 shares with an exercise price of $84.06. Following the RSU grant, Ms. John directly beneficially owns 18,455 shares and indirectly holds 5,382 shares through the issuer's 401(k) plan trustee.

The stock option vests in equal annual installments over three years beginning on 09/11/2026 and expires on 09/11/2033. The RSUs vest in three equal one-year installments starting on the grant date.

Malcolm Gregory, Executive Vice President and Controller of Colgate-Palmolive Company (CL), reported equity awards granted on 09/11/2025. He received 1,119 restricted stock units (RSUs) that vest in three equal annual installments beginning one year after grant and 7,743 stock options with an exercise price of $84.06. The options vest in equal annual installments over three years beginning on the first anniversary of the grant and expire on 09/11/2033. Following these transactions, Mr. Gregory directly beneficially owns 12,146 shares and indirectly owns 8,445 shares through the issuer's 401(k) plan trustee.

Grant Shane, COO, Americas at Colgate-Palmolive Company, reported equity awards on 09/11/2025. The filing shows a grant of 3,569 restricted stock units (RSUs) that vest in equal one-third installments on each of the first three anniversaries of the grant. The report also records a stock option award for 24,712 shares with an exercise price of $84.06; the option vests in equal annual installments over three years beginning on the first anniversary of the grant and expires on 09/11/2033. After these transactions, the reporting person beneficially owns 94,119 common shares and holds 24,712 underlying shares from the option award.

Jennifer Daniels, Chief Legal Officer and Secretary of Colgate-Palmolive Company (CL), reported equity awards granted on 09/11/2025. The filing shows a non-derivative acquisition of 4,592 common stock units (restricted stock units) at $0.00, leaving 77,980 shares directly beneficially owned after the transaction, plus 1,813 indirectly owned through the issuer's 401(k) plan trustee. The filing also reports a stock option award with an $84.06 exercise price for 31,796 options, exercisable in equal annual installments over three years beginning on the first anniversary of the 09/11/2025 grant and expiring 09/11/2033. The RSUs vest in three equal annual installments from the grant date. The form is signed by an attorney-in-fact on 09/12/2025.